NCT06799780 Study on Post-acute Myocardial Infarction Ventricular Defect: Outcome Evalutation in Relation to Surgical Timing
| NCT ID | NCT06799780 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna |
| Condition | Myocardial Infarction (MI) |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2024-02-12 |
| Primary Completion | 2026-11-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2024-02-12 with a primary completion date of 2026-11-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The main objective of the study is to identify the optimal surgical timing for the treatment of intraventricular defects after acute myocardial infarction.
Eligibility Criteria
Inclusion Criteria: * Patients over eighteen years of age * Patients with post-myocardial infarction ventricular septal defect treated surgically * Patients who have signed the informed consent Exclusion Criteria: * Patients with post-infarction ventricular septal defect treated with medical/conservative therapy * Patients with ventricular septal defects not due to acute myocardial infarction
Contact & Investigator
Luca Di Marco, MD
PRINCIPAL INVESTIGATOR
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Frequently Asked Questions
Who can join the NCT06799780 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Myocardial Infarction (MI). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06799780 currently recruiting?
Yes, NCT06799780 is actively recruiting participants. Contact the research team at luca.dimarco@aosp.bo.it for enrollment information.
Where is the NCT06799780 trial being conducted?
This trial is being conducted at Bologna, Italy, Udine, Italy, Varese, Italy, Barcelona, Spain.
Who is sponsoring the NCT06799780 clinical trial?
NCT06799780 is sponsored by IRCCS Azienda Ospedaliero-Universitaria di Bologna. The principal investigator is Luca Di Marco, MD at IRCCS Azienda Ospedaliero-Universitaria di Bologna. The trial plans to enroll 100 participants.